OTCMKTS:OWCP

OWC Pharmaceutical Research Stock Forecast, Price & News

$0.0089
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.02
52-Week Range
$0.01
Now: $0.01
$0.03
Volume842,497 shs
Average Volume6.30 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.
OWC Pharmaceutical Research logo

Industry, Sector and Symbol

Industry Miscellaneous
Sub-IndustryCannabis
Current SymbolOTCMKTS:OWCP
CUSIPN/A
CIKN/A
Phone(723) 770-4330
Employees9
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

OWC Pharmaceutical Research Corp
March 19, 2021 |  bloomberg.com
News for OWC Pharmaceutical Research Corp
December 24, 2020 |  markets.businessinsider.com
OWC Pharmaceutical Research Corp (OWCP)
November 3, 2020 |  nasdaq.com
OWC Pharmaceutical Research Corp.
April 30, 2020 |  www.barrons.com
OWC Pharmaceutical Research Corp. (OWCP)
March 24, 2020 |  finance.yahoo.com
OWC Pharmaceutical Research Corp, Letter to Shareholders
February 11, 2019 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.58 out of 5 stars

Miscellaneous Sector

28th out of 172 stocks

Miscellaneous Industry

2nd out of 7 stocks

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0089
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OWCP News and Ratings via Email

Sign-up to receive the latest news and ratings for OWCP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OWC Pharmaceutical Research (OTCMKTS:OWCP) Frequently Asked Questions

What stocks does MarketBeat like better than OWC Pharmaceutical Research?

Wall Street analysts have given OWC Pharmaceutical Research a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but OWC Pharmaceutical Research wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has OWC Pharmaceutical Research's stock been impacted by Coronavirus (COVID-19)?

OWC Pharmaceutical Research's stock was trading at $0.0230 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OWCP stock has decreased by 61.3% and is now trading at $0.0089.
View which stocks have been most impacted by COVID-19
.

Who are OWC Pharmaceutical Research's key executives?

OWC Pharmaceutical Research's management team includes the following people:
  • Mr. Alon Sinai, Chief Operating Officer (Age 54, Pay $94k)
  • Dr. Yehuda Baruch, Chief Medical & Regulatory Affairs Officer (Age 64, Pay $112k)
  • Mr. Ziv Turner, Chief Exec. Officer (Age 48)
  • Mr. Shmuel De-Saban, CFO & Sec. (Age 55)
  • Dr. Oron Yacoby-Zeevi, Chief Scientific Officer (Age 60)
  • Prof. Yuval Ramot, Consultant

Who are some of OWC Pharmaceutical Research's key competitors?

What other stocks do shareholders of OWC Pharmaceutical Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OWC Pharmaceutical Research investors own include Co-Diagnostics (CODX), The GEO Group (GEO), PharmaCyte Biotech (PMCB), iBio (IBIO), Inovio Pharmaceuticals (INO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aurora Cannabis (ACB) and Kopin (KOPN).

What is OWC Pharmaceutical Research's stock symbol?

OWC Pharmaceutical Research trades on the OTCMKTS under the ticker symbol "OWCP."

How do I buy shares of OWC Pharmaceutical Research?

Shares of OWCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OWC Pharmaceutical Research's stock price today?

One share of OWCP stock can currently be purchased for approximately $0.01.

How many employees does OWC Pharmaceutical Research have?

OWC Pharmaceutical Research employs 9 workers across the globe.

What is OWC Pharmaceutical Research's official website?

The official website for OWC Pharmaceutical Research is www.owcpharma.com.

Where are OWC Pharmaceutical Research's headquarters?

OWC Pharmaceutical Research is headquartered at 30 Shacham Street. P.O.B. 8324, PETAH TIKVA, 4918103, Israel.

How can I contact OWC Pharmaceutical Research?

OWC Pharmaceutical Research's mailing address is 30 Shacham Street. P.O.B. 8324, PETAH TIKVA, 4918103, Israel. The company can be reached via phone at (723) 770-4330.


This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.